NPI: 1013468172 · COSHOCTON, OH 43812 · Internal Medicine Physician · NPI assigned 10/24/2016
Authorized official DOAN, CHRISTOPHER controls 20+ related entities in our dataset. Read more
| Authorized Official | DOAN, CHRISTOPHER (MANAGING ASSOCIATE GENERAL COUNSEL) |
| NPI Enumeration Date | 10/24/2016 |
Other providers sharing the same authorized official: DOAN, CHRISTOPHER
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 50,271 | $1.62M |
| 2019 | 43,196 | $1.49M |
| 2020 | 32,057 | $1.51M |
| 2021 | 41,819 | $1.72M |
| 2022 | 47,483 | $1.96M |
| 2023 | 106,307 | $2.95M |
| 2024 | 71,820 | $2.07M |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | 21,388 | 18,257 | $1.71M |
| 99283 | Emergency department visit for the evaluation and management, moderate severity | 19,113 | 17,639 | $1.69M |
| 99285 | Emergency department visit for the evaluation and management, high severity with immediate threat to life | 12,428 | 10,529 | $1.45M |
| 99284 | Emergency department visit for the evaluation and management, high severity | 15,209 | 13,811 | $1.43M |
| 99213 | Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 34,640 | 28,858 | $1.41M |
| 99214 | Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 29,292 | 25,805 | $1.10M |
| 96361 | Intravenous infusion, hydration; each additional hour | 4,576 | 3,595 | $1.06M |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 4,813 | 4,306 | $429K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 5,019 | 4,609 | $374K |
| 70450 | Computed tomography, head or brain; without contrast material | 1,238 | 1,028 | $238K |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | 2,974 | 764 | $214K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 917 | 712 | $211K |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | 960 | 819 | $207K |
| 80053 | Comprehensive metabolic panel | 16,713 | 13,976 | $201K |
| 92507 | Treatment of speech, language, voice, communication, and/or auditory processing disorder | 1,450 | 518 | $120K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | 1,251 | 835 | $114K |
| 36415 | Collection of venous blood by venipuncture | 11,879 | 9,711 | $102K |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | 998 | 709 | $97K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 11,687 | 5,296 | $82K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 1,926 | 1,742 | $60K |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | 412 | 302 | $49K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 19,855 | 16,304 | $47K |
| 87070 | 2,412 | 2,229 | $43K | |
| 80048 | Basic metabolic panel (calcium, ionized) | 2,402 | 1,828 | $42K |
| 97161 | 520 | 468 | $40K | |
| 99203 | Office or other outpatient visit for the evaluation and management of a new patient, low complexity | 963 | 904 | $40K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 5,332 | 4,816 | $38K |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | 346 | 312 | $35K |
| 99233 | Prolong inpt eval add15 m | 1,741 | 853 | $29K |
| 87400 | 1,886 | 908 | $26K | |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 6,747 | 5,273 | $26K |
| 97530 | Therapeutic activities, direct patient contact, each 15 minutes | 365 | 149 | $26K |
| 87086 | Culture, bacterial; quantitative colony count, urine | 3,198 | 2,672 | $25K |
| C8929 | Transthoracic echocardiography with contrast, or without contrast followed by with contrast, real-time with image documentation (2d), includes m-mode recording, when performed, complete, with spectral doppler echocardiography, and with color flow doppler echocardiography | 125 | 92 | $23K |
| 99215 | Prolong outpt/office vis | 611 | 533 | $21K |
| 99223 | Prolong inpt eval add15 m | 584 | 526 | $21K |
| 84484 | 7,011 | 4,342 | $21K | |
| 73630 | 533 | 485 | $20K | |
| 71275 | Computed tomographic angiography, chest, with contrast material | 101 | 74 | $19K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 1,300 | 1,056 | $19K |
| 71046 | Radiologic examination, chest; 2 views | 2,876 | 2,641 | $18K |
| 80061 | Lipid panel | 2,440 | 2,147 | $18K |
| 99406 | 598 | 485 | $16K | |
| 83036 | Hemoglobin; glycosylated (A1C) | 2,100 | 1,841 | $16K |
| 87081 | 1,462 | 1,285 | $16K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 4,290 | 2,757 | $15K |
| 99232 | Subsequent hospital care, per day, moderate complexity | 1,258 | 683 | $14K |
| G0378 | Hospital observation service, per hour | 299 | 202 | $14K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 157 | 147 | $13K |
| C9113 | Injection, pantoprazole sodium, per vial | 130 | 74 | $13K |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | 2,613 | 2,220 | $13K |
| 96366 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour | 93 | 59 | $12K |
| 99204 | Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | 255 | 201 | $11K |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 765 | 659 | $11K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 4,880 | 4,020 | $11K |
| 73610 | 250 | 207 | $10K | |
| 84443 | Thyroid stimulating hormone (TSH) | 937 | 824 | $9K |
| 99239 | Hospital discharge day management, more than 30 minutes | 419 | 391 | $9K |
| 71045 | Radiologic examination, chest; single view | 4,718 | 3,826 | $9K |
| 82607 | 477 | 417 | $9K | |
| 96375 | Therapeutic injection; each additional sequential IV push | 3,812 | 2,916 | $8K |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | 262 | 255 | $6K |
| J7030 | Infusion, normal saline solution , 1000 cc | 8,596 | 5,726 | $6K |
| 43239 | Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple | 20 | 12 | $6K |
| 81001 | 5,644 | 4,981 | $6K | |
| 81025 | 1,779 | 1,578 | $6K | |
| 73130 | 188 | 151 | $5K | |
| 77063 | Screening digital breast tomosynthesis, bilateral | 114 | 106 | $5K |
| 97113 | 114 | 31 | $5K | |
| 99222 | Initial hospital care, per day, moderate complexity | 188 | 172 | $5K |
| 85610 | 3,829 | 3,120 | $5K | |
| 83690 | 3,313 | 2,767 | $4K | |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | 42 | 38 | $4K |
| 84439 | 332 | 295 | $4K | |
| 73030 | 169 | 125 | $4K | |
| 84702 | 824 | 660 | $4K | |
| 73562 | 83 | 62 | $3K | |
| 99291 | Critical care, evaluation and management of the critically ill patient, first 30-74 minutes | 53 | 38 | $3K |
| 87186 | 859 | 723 | $3K | |
| 83605 | 1,684 | 1,183 | $3K | |
| 83880 | 612 | 466 | $3K | |
| 83735 | 1,116 | 833 | $3K | |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | 162 | 142 | $3K |
| 85379 | 949 | 747 | $3K | |
| 87807 | 793 | 723 | $3K | |
| 85730 | 2,784 | 2,297 | $3K | |
| 93971 | 32 | 25 | $3K | |
| 82728 | 184 | 146 | $2K | |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | 166 | 133 | $2K |
| 99457 | 200 | 199 | $2K | |
| 83540 | 324 | 264 | $2K | |
| 81003 | 2,657 | 2,301 | $2K | |
| 85027 | 852 | 656 | $2K | |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed | 442 | 357 | $2K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | 162 | 142 | $2K |
| 81002 | 495 | 422 | $2K | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | 3,278 | 2,336 | $2K |
| 73110 | 30 | 27 | $1K | |
| 82553 | 182 | 147 | $1K | |
| 99458 | 38 | 37 | $1K | |
| 90686 | 97 | 84 | $1K | |
| 80076 | 163 | 123 | $1K | |
| 74018 | 48 | 37 | $1K | |
| 86140 | 109 | 86 | $1K | |
| 99441 | 166 | 155 | $1K | |
| 77067 | Screening mammography, bilateral, including computer-aided detection | 114 | 106 | $941.70 |
| G0008 | Administration of influenza virus vaccine | 128 | 111 | $922.13 |
| 94760 | 197 | 108 | $848.30 | |
| 96376 | 414 | 236 | $785.24 | |
| G0179 | Physician or allowed practitioner re-certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and allowed practitioners to affirm the initial implementation of the plan of care | 64 | 50 | $767.16 |
| 85652 | 269 | 223 | $761.20 | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | 2,999 | 2,376 | $749.58 |
| 99201 | 96 | 66 | $685.90 | |
| 72125 | Computed tomography, cervical spine; without contrast material | 127 | 99 | $666.80 |
| 82550 | 554 | 424 | $643.84 | |
| 82948 | 642 | 375 | $642.85 | |
| 82746 | 48 | 40 | $591.00 | |
| 82150 | 380 | 339 | $571.66 | |
| 99238 | Hospital discharge day management, 30 minutes or less | 25 | 24 | $520.14 |
| 83550 | 54 | 40 | $434.98 | |
| 86803 | 17 | 13 | $421.86 | |
| 82525 | 12 | 12 | $275.51 | |
| 73502 | 15 | 12 | $257.12 | |
| J1170 | Injection, hydromorphone, up to 4 mg | 452 | 192 | $215.59 |
| J2270 | Injection, morphine sulfate, up to 10 mg | 797 | 524 | $190.35 |
| 99454 | 70 | 70 | $188.36 | |
| 80320 | 49 | 43 | $185.76 | |
| 99442 | 13 | 13 | $181.65 | |
| 88142 | 15 | 13 | $181.14 | |
| 84630 | 12 | 12 | $175.35 | |
| 84703 | 67 | 56 | $109.00 | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | 224 | 134 | $105.22 |
| 84100 | 23 | 15 | $79.52 | |
| 99490 | Ccm add 20min | 25 | 25 | $74.61 |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | 20 | 20 | $66.88 |
| J7120 | Ringers lactate infusion, up to 1000 cc | 424 | 228 | $45.76 |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 1,734 | 1,383 | $29.88 |
| J3010 | Injection, fentanyl citrate, 0.1 mg | 894 | 587 | $23.42 |
| J2360 | Injection, orphenadrine citrate, up to 60 mg | 63 | 62 | $21.60 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | 617 | 501 | $18.56 |
| 36416 | 27 | 27 | $11.43 | |
| J2765 | Injection, metoclopramide hcl, up to 10 mg | 202 | 130 | $8.76 |
| J7620 | Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme | 120 | 109 | $4.28 |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | 484 | 319 | $2.23 |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | 166 | 118 | $1.90 |
| J0690 | Injection, cefazolin sodium, 500 mg | 212 | 131 | $1.48 |
| J2704 | Injection, propofol, 10 mg | 944 | 683 | $1.17 |
| 3074F | 4,372 | 3,889 | $0.53 | |
| J7512 | Prednisone, immediate release or delayed release, oral, 1 mg | 131 | 108 | $0.36 |
| 3078F | 3,432 | 3,051 | $0.34 | |
| J2001 | Injection, lidocaine hcl for intravenous infusion, 10 mg | 692 | 509 | $0.18 |
| 3079F | 712 | 635 | $0.18 | |
| 91300 | 16 | 15 | $0.10 | |
| 3080F | 16 | 13 | $0.07 | |
| 3077F | 32 | 30 | $0.06 | |
| 3044F | 110 | 102 | $0.03 | |
| 3075F | 64 | 61 | $0.01 | |
| 3008F | 13,004 | 11,537 | $0.01 | |
| 1160F | 15,424 | 13,691 | $0.00 | |
| 4004F | 67 | 62 | $0.00 | |
| 3288F | 984 | 938 | $0.00 | |
| G9562 | Patients who had a follow-up evaluation conducted at least every three months during opioid therapy | 132 | 126 | $0.00 |
| G9577 | Patients prescribed opiates for longer than six weeks | 133 | 127 | $0.00 |
| G8427 | Eligible clinician attests to documenting in the medical record they obtained, updated, or reviewed the patient's current medications | 333 | 316 | $0.00 |
| G9584 | Patient evaluated for risk of misuse of opiates by using a brief validated instrument (e.g., opioid risk tool, soapp-r) or patient interviewed at least once during opioid therapy | 129 | 124 | $0.00 |
| G9578 | Documentation of signed opioid treatment agreement at least once during opioid therapy | 133 | 127 | $0.00 |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | 52 | 37 | $0.00 |
| G9561 | Patients prescribed opiates for longer than six weeks | 132 | 126 | $0.00 |
| G8730 | Pain assessment documented as positive using a standardized tool and a follow-up plan is documented | 251 | 236 | $0.00 |
| J1171 | Injection, hydromorphone, 0.1 mg | 36 | 18 | $0.00 |
| J2550 | Injection, promethazine hcl, up to 50 mg | 21 | 15 | $0.00 |
| 90461 | 14 | 14 | $0.00 | |
| 01992 | 25 | 17 | $0.00 | |
| 1126F | 2,930 | 2,633 | $0.00 | |
| J2060 | Injection, lorazepam, 2 mg | 51 | 40 | $0.00 |
| 1125F | 1,346 | 1,149 | $0.00 | |
| G9583 | Patients prescribed opiates for longer than six weeks | 130 | 124 | $0.00 |
| A9270 | Non-covered item or service | 202 | 173 | $0.00 |
| 1036F | 100 | 95 | $0.00 | |
| J1030 | Injection, methylprednisolone acetate, 40 mg | 16 | 15 | $0.00 |
| J7050 | Infusion, normal saline solution, 250 cc | 44 | 24 | $0.00 |